Health
Research into COVID treatments catching up – Esperance Express
Australia has closed a deal for 300,000 courses of an antiviral pill showing promising signs of slashing COVID-19 deaths and…
Australia has closed a deal for 300,000 courses of an antiviral pill showing promising signs of slashing COVID-19 deaths and hospitalisations.
Molnupiravir is still being trialled in the US and is yet to gain regulatory authorisation.
But the federal government…
Continue Reading
-
Noosa News17 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General17 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
General22 hours agoDe-escalation skills, not guards, needed in Tasmanian hospitals, nurses’ union says
-
Noosa News18 hours agoThe Best Things to Do in Brisbane This New Year’s Eve